Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 225,000 shares at $20.20 ($4.6M) on 2018-11-29, disclosed to the SEC on 2018-12-03.
Open-market sale of $4.6M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.20 | 50,000 | $1.0M | 21.9% |
| 2 | $20.48 | 75,000 | $1.5M | 33.3% |
| 3 | $20.70 | 100,000 | $2.1M | 44.8% |
| Total | $20.52 avg | 225,000 | $4.6M | 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |